EI
CATX icon

EAM Investors’s Perspective Therapeutics CATX Stock Holding History

EAM Investors’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-32,631
Closed -$325K – 255
2024
Q2 		$325K Sell
32,631
-51,685
-61% -$747K 0.05% 240
2024
Q1 		$1M Buy
+84,316
New +$719K 0.16% 168
2020
Q3 		– Sell
-31,010
Closed -$172K – 289
2020
Q2 		$172K Sell
31,010
-77,095
-71% -$496K 0.04% 254
2020
Q1 		$573K Buy
+108,105
New +$816K 0.18% 192

Other funds holding CATX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NWMG
Nicholson Wealth Management Group Charlestown, South Carolina $170M AUM 10.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

EAM Investors's CATX Position: Q3 2024 in Review

EAM Investors sold out of Perspective Therapeutics (CATX) in Q3 2024, closing a stake of 32,631 shares — an estimated $325K sold.

EAM Investors first reported a position in CATX in Q1 2020 and held it in 4 quarters. The position peaked at $1M in Q1 2024. 127 funds tracked by Wall St. Rank hold CATX as of Q3 2024.

  • EAM Investors reported no remaining Perspective Therapeutics position as of Q3 2024 after selling out during the quarter.
  • EAM Investors sold 32,631 Perspective Therapeutics shares in Q3 2024, an estimated $325K.
  • EAM Investors first reported a position in Perspective Therapeutics in Q1 2020 and held it in 4 quarters.
  • EAM Investors's Perspective Therapeutics position peaked at $1M in Q1 2024.
  • 127 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q3 2024.

Based on EAM Investors's 13F filing for Q3 2024, filed 13 Nov 2024.